๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Generation of an oligonucleotide array for analysis of gene expression inChlamydomonas reinhardtii

โœ Scribed by Stephan Eberhard; Monica Jain; Chung Soon Im; Steve Pollock; Jeff Shrager; Yuan Lin; Andrew S. Peek; Arthur R. Grossman

Publisher
Springer-Verlag
Year
2005
Tongue
English
Weight
435 KB
Volume
49
Category
Article
ISSN
0172-8083

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Overlay analysis of the oligonucleotide
Overlay analysis of the oligonucleotide array gene expression profiles and copy number abnormalities as determined by array comparative genomic hybridization in medulloblastomas
โœ Ken C. Lo; Michael R. Rossi; Tania Burkhardt; Scott L. Pomeroy; John K. Cowell ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 459 KB

## Abstract Combined analysis of gene expression array data and arrayโ€based comparative genomic hybridization data have been used in a series of 26 pediatric brain tumors to define upโ€ and downregulated genes that coincide with losses, gains, and amplifications involving specific chromosome regions

An iterative procedure for differential
An iterative procedure for differential analysis of gene expression
โœ Avner Bar-Hen; Stรฉphane Robin ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 82 KB

Microarrays are a popular technology to study genes that are differentially expressed between two conditions. In this Note, we propose an iterative procedure to determine the biggest subset of non-differentially expressed genes. We prove a pseudo Markov relationship that allows practical computation

Comparative gene expression analysis of
Comparative gene expression analysis of a chronic myelogenous leukemia cell line resistant to cyclophosphamide using oligonucleotide arrays and response to tyrosine kinase inhibitors
โœ Fei Bao; Paula Polk; Mary L. Nordberg; Diana M. Veillon; Amanda Sun; Michael Dei ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 471 KB

Acquired imatinib resistance in chronic myelogenous leukemia (CML) can be the consequence of mutations in the kinase domain of BCR-ABL or increased protein levels. However, as in other malignancies, acquired resistance to cytostatic drugs is a common reason for treatment failure or disease progressi